BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30791825)

  • 1. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
    Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
    Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
    Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma?
    Nakahashi K; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Onoe S; Watanabe N; Nagino M
    Surgery; 2020 Oct; 168(4):617-624. PubMed ID: 32665142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin.
    Shinohara K; Shimoyama Y; Ebata T; Yokoyama Y; Mizuno T; Nakaguro M; Nagino M
    Surgery; 2017 Jul; 162(1):84-93. PubMed ID: 28187867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection.
    Ito T; Kuriyama N; Kozuka Y; Komatsubara H; Ichikawa K; Noguchi D; Hayasaki A; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    BMC Cancer; 2020 Mar; 20(1):209. PubMed ID: 32164621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.
    Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Narasaki H; Amano T; Shichinohe T; Hirano S
    Ann Surg Oncol; 2020 Oct; 27(11):4171-4180. PubMed ID: 32363510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic micropapillary neoplasm of peribiliary glands with concomitant perihilar cholangiocarcinoma.
    Uchida T; Yamamoto Y; Ito T; Okamura Y; Sugiura T; Uesaka K; Nakanuma Y
    World J Gastroenterol; 2016 Feb; 22(7):2391-7. PubMed ID: 26900302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.